GENVEC
GenVec, Inc. (NASDAQ: GNVC) GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant hum... an and animal health concerns. GenVecโs development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD).
GENVEC
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1992-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.genvec.com
Total Employee:
11+
Status:
Active
Contact:
3019441894
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
JQuery CDN DigiCert SSL Apple Whitelist
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AscentGene
AscentGene specializes in cell lines services, protein & enzymes research, gene function studies & monoclonal antibody production solutions.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Peptinovo Biopharma
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - GenVec
More informations about "GenVec"
GenVec - Crunchbase Company Profile & Funding
GenVec, Inc. (NASDAQ: GNVC) GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines.See details»
GenVec, Inc - Scientist.com
GenVec is an clinical-stage biopharmaceutical company with an entrepreneurial focus on leveraging its AdenoVerseโข gene delivery platform to develop a pipeline of cutting-edge โฆSee details»
GenVec - LinkedIn
GenVec | 1,641 followers on LinkedIn. GenVec is an entrepreneurial clinical-stage biopharmaceutical company focused on leveraging its proprietary adenovector gene delivery โฆSee details»
GenVec - Products, Competitors, Financials, Employees, โฆ
Headquarters Location. 910 Clopper Road Suite 220N. Gaithersburg, Maryland, 20878, United States. 240-632-0740See details»
Genvec Company Profile 2024: Valuation, Investors, Acquisition
Genvec General Information Description. Developer of a gene delivery platform to provide a pipeline of cutting-edge therapeutics and vaccines. The company's platform uses proprietary โฆSee details»
GenVec Company Profile - Office Locations, Competitors ... - Craft
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.See details»
GenVec, Inc. - EverybodyWiki Bios & Wiki
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company working to build a pipeline of therapeutics and vaccines based on its adenovector technology platform that can realize the โฆSee details»
GenVec, Inc. - Company Profile & Staff Directory | ContactOut
GenVec is an entrepreneurial clinical-stage biopharmaceutical company focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge โฆSee details»
GenVec, Inc. - VentureRadar
Website: http://www.genvec.com/ Develops gene therapy products aimed at treating various diseases, utilizing advanced technology to target specific genetic issues.See details»
GenVec - Funding, Financials, Valuation & Investors - Crunchbase
GenVec is a biopharmaceutical company employing differentiated, proprietary technologies for the creation of therapeutics and vaccines.See details»
GenVec, Inc.:Company Profile & Technical Research,Competitor โฆ
Discovery Company profile page for GenVec, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
GENVECโs Competitors, Revenue, Number of Employees, Funding โฆ
GENVECโs Profile, Revenue and Employees. GenVec is a biopharmaceutical company that develops and builds a pipeline of therapeutics and vaccines for gene-based diseases. โฆSee details»
GenVec - Ownership and Business Overview - Mergr
Jan 24, 2017 Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017.The largest life science acquisition in 2017 was Actelion - which was acquired by โฆSee details»
GenVec - Contacts, Employees, Board Members, Advisors
GenVec is a biopharmaceutical company employing differentiated, proprietary technologies for the creation of therapeutics and vaccines.See details»
GenVec, Inc. - VentureRadar
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company working to build a pipeline of therapeutics and vaccines based on its adenovector... ... Find out more ...See details»
GenVec, Inc. - Center For Technology Licensing
Mar 20, 2018 GenVec, Inc., is a biopharmaceutical company developing therapeutic drugs for cancer and vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, โฆSee details»
GenVec, Inc. Company Insights, Tech Stack, and Competitors
GenVec is an entrepreneurial clinical-stage biopharmaceutical company focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge โฆSee details»
GenVec, Inc. (GenVec, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆ โฆ
In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD 50/90) for prevention of clinical FMD.In vaccinated, contact-challenged โฆSee details»
GenVec - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 8, 2024 GenVec is a biopharmaceutical company employing differentiated, proprietary technologies for the creation of therapeutics and vaccines.See details»
Canadian organization combats loneliness | CTV News - CTV News โฆ
1 day ago Canadian organization teaches people to combat loneliness through connection during holiday season. Wrongfully convicted N.B. man has mixed feelings since exoneration โฆSee details»